The nucleic acid detection kit developed by the Tsinghua University team and Beijing Xinyi Biotech has been approved for listing_ Securities Times

According to news from Tsinghua University on January 15, the new coronavirus (2019-nCoV) nucleic acid detection kit jointly developed by the team of Professor Guo Yong of Tsinghua University School of Medicine and Beijing Xinyi Biotechnology Co., Ltd. (Fluorescent PCR method), recently officially obtained the medical device approval from the National Medical Products Administration (NMPA). According to reports, this is the first Class III medical device certificate approved by the State Food and Drug Administration for the detection of new coronavirus nucleic acid based on digital PCR technology. results. The kit adopts the third-generation PCR technology, and the sensitivity can reach 100 copies/mL, which effectively improves the detection sensitivity.